Efficacy and safety of thoracic radiotherapy combined with anti-angiogenic therapy and immunochemotherapy for advanced non-small cell lung cancer patients: a retrospective study [0.03%]
胸部放疗联合抗血管生成及免疫化疗治疗晚期非小细胞肺癌的疗效和安全性回顾性分析
Kai Gai,Xuexin Shi,Fei Xu et al.
Kai Gai et al.
Purpose: To assess the efficacy and safety of radiotherapy combined with anti-angiogenic therapy, immune checkpoint inhibitors, and chemotherapy for advanced non-small cell lung cancer (NSCLC). ...
Development and validation of a deep learning model using MR imaging for predicting brain metastases: an accuracy-focused study [0.03%]
基于准确性的眼部MR影像深度学习模型的开发与验证研究预测脑转移灶
Dan Shi,Meng Yang,Min Dong et al.
Dan Shi et al.
Background: Brain metastases (BM), originating from extracranial malignancies, significantly threaten patient health. Accurate BM identification is crucial but labor-intensive manually. This study developed and validated ...
Perioperative nursing care strategies in esophageal cancer surgery: a mini-review [0.03%]
食管癌手术的围术期护理策略：小结形式发表
Yu-Feng Li,Ji-Hong Tao,Chen-Chen Wang et al.
Yu-Feng Li et al.
This study reviews contemporary clinical trials on perioperative nursing care management (PNCM) in esophageal cancer (EC) surgery. It evaluates four key phases of care: preoperative preparation (patient education and physiological optimizat...
Predicting the recurrence risk of liver metastasis from colorectal cancer: a study based on preoperative CT intratumoral and peritumoral radiomics features [0.03%]
基于术前CT影像组学特征的结直肠癌肝转移复发风险预测研究
Dongying Zhang,Peiheng Li,Yong Wei et al.
Dongying Zhang et al.
Objective: This study aims to explore the value of predicting the recurrence risk of colorectal cancer liver metastasis (CRLM) based on preoperative CT intratumoral and peritumoral radiomics features. ...
Assessing the reliability and responsiveness of the SF-6Dv2 and comparing its validity to the EQ-5D-5L among colorectal cancer patients in China [0.03%]
在中国结直肠癌患者中评估SF-6D v2的可靠性和灵敏度并将其与EQ-5D-5L的有效性进行比较
Jiannan Sun,Lijun Xu,Yiyin Cao et al.
Jiannan Sun et al.
Objective: This study aimed to evaluate the reliability and responsiveness of the SF-6Dv2, and to provide the first comparative assessment of its validity against the EQ-5D-5L in Chinese patients with colorectal cancer (C...
Case Report: Metastasis to pleura and mediastinal lymph nodes from breast secretory carcinoma: 10 years follow-up [0.03%]
案例报道：分泌性乳腺癌胸膜及纵隔淋巴结转移的十年随访
Fengbo Huang,Jing Zhao,Jie Lian et al.
Fengbo Huang et al.
Breast secretory carcinoma (BSC) is a rare low-grade malignancy that frequently exhibits the ETV6::NTRK3 fusion gene and rarely presents with distant metastasis. In this report, we describe a case of 72-year-old female diagnosed with BSC, w...
Pelvic venous and pulmonary artery extension in low-grade endometrial stromal sarcoma: a case report [0.03%]
低级别子宫内膜间质肉瘤累及盆腔静脉和肺动脉1例报告
Yi-Ling Li,Xin Sun,Ming-Zhu Ye et al.
Yi-Ling Li et al.
Background: Vascular invasion is a hallmark of low-grade endometrial stromal sarcoma (LG-ESS), typically presenting a tumor thrombus within the parametrial vessels. However, extension of tumor thrombus into major vessels ...
Case Report: Malignant phyllodes tumor of the breast with heterologous osteosarcomatous differentiation and literature review [0.03%]
恶性叶状肿瘤合并异源性骨肉瘤样分化的1例报告及文献复习
Liang Guo,Jing Wang,Xiang Li et al.
Liang Guo et al.
Phyllodes tumor (PT) of the breast is a rare fibroepithelial tumor characterized by the proliferation of both epithelial and stromal components. The presence of osteosarcomatous differentiation within the sarcomatous stroma is exceptionally...
Prognostic factors and treatment outcomes in EGFR-mutated NSCLC with malignant pleural effusion: focus on intrathoracic chemotherapy and EGFR-TKI therapy [0.03%]
恶性胸腔积液EGFR突变型非小细胞肺癌的预后因素及治疗效果：局部化疗和靶向治疗疗效分析
Zhuohao Huang,Jinmei Li,Haiyin Ye et al.
Zhuohao Huang et al.
Objective: In treatment-naïve patients with EGFR-mutated non-small-cell lung cancer (NSCLC) complicated by malignant pleural effusion (MPE), we first investigated whether the addition of intrathoracic chemotherapy (ICT) ...
Hongfeng Wang,Jianbin Chen
Hongfeng Wang
Multiple myeloma (MM) is a common hematologic malignancy characterized by clonal plasma cell proliferation. Despite significant therapeutic advancements with proteasome inhibitors, immunomodulatory drugs, and anti-B-cell maturation antigen ...